|
1
|
Levine AJ: The tumor suppressor genes.
Annu Rev Biochem. 62:623–651. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Knudson AG Jr: Genetics and etiology of
human cancer. Adv Hum Genet. 8:1–66. 1977.PubMed/NCBI
|
|
3
|
Knudson AG Jr: Mutation and cancer:
statistical study of retinoblastoma. Proc Natl Acad Sci USA.
68:820–823. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolman SR, Pauley RJ, Mohamad AN, Dawson
PJ, Visscher DW and Sarkar FH: Genetic markers as prognostic
indicators in breast cancer. Cancer. 70:1765–1774. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitelman F: Catalogue of Chromosome
Aberration in Cancer. 4th edition. Willey-Liss; New York, NY:
1991
|
|
6
|
Lengauer C, Kinzler KW and Vogelstein B:
Genetic instabilities in human cancers. Nature. 396:643–649. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Devilee P, Van den Broek M,
Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL and Cornelisse
CJ: At least four different chromosomal regions are involved in
loss of heterozygosity in human breast carcinoma. Genomics.
5:554–560. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anderson TI, Gaustad A, Ottestad L,
Farrants GW, Nesland JM, Tveit KM and Borresen AL: Genetic
alterations of the tumor suppressor gene regions 3p, 11p, 17p, and
17q in human breast carcinomas. Genes Chromosomes Cancer.
4:113–121. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roy D, Calaf G and Hei TK: Frequent
allelic imbalance on chromosome 6 and 17 correlate with
radiation-induced neoplastic transformation of human breast
epithelial cells. Carcinogenesis. 22:1685–1692. 2001. View Article : Google Scholar
|
|
10
|
Winqvist R, Mannermaa A, Alavaikko M,
Blanco G, Kiviniemi H, Taskinen PJ, Kiviniemi H, Newsham I and
Cavenee W: Refinement of regional loss of heterozygosity for
11p15.5 in human breast tumors. Cancer Res. 53:4486–4488.
1993.PubMed/NCBI
|
|
11
|
Hampton G, Mannermaa A, Winqvist R,
Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee
W and Evans GA: Loss of heterozygosity in sporadic human breast
carcinoma: a common region between 11q22 and 11q23.3. Cancer Res.
54:4586–4589. 1994.PubMed/NCBI
|
|
12
|
Negrini M, Sabbioni S, Possati L, Rattan
S, Corallini A, Barbanti-Brodano G and Croce CM: Suppression of
tumorigenecity of breast cancer cells by microcell-mediated
chromosome transfer: studies on chromosome 6 and 11. Cancer Res.
54:1331–1336. 1994.PubMed/NCBI
|
|
13
|
Rosa-Rosa JM, Pita G, González-Neira A,
Milne RL, Fernandez V, Ruivenkamp C, van Asperen CJ, Devilee P and
Benitez J: A 7 Mb region within 11q13 may contain a high penetrance
gene for breast cancer. Breast Cancer Res Treat. 118:151–159. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karlsson E, Waltersson MA, Bostner J,
Pérez-Tenorio G, Olsson B, Hallbeck AL and Stäl O: High-resolution
genomic analysis of the 11q13 amplicon in breast cancers identifies
synergy with 8p12 amplification, involving the mTOR targets S6K2
and 4EBP1. Genes Chromosomes Cancer. 50:775–787. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lizard-Nacol S, Lidereau R, Collin FA,
Arnal M, Hahnel L, Roignot P, Cuisenier J and Guerrin J: Benign
breast disease: absence of genetic alterations at several loci
implicated in breast cancer malignancy. Cancer Res. 55:4416–4419.
1995.PubMed/NCBI
|
|
16
|
Fantl V, Smith R, Brookes S, Dickson C and
Peters G: Chromosome 11q13 abnormalities in human breast cancer.
Cancer Surv. 18:77–94. 1993.PubMed/NCBI
|
|
17
|
Champème MH, Bièche I, Hacène K and
Lidereau R: Int-2/FGF3 amplification is a better independent
predictor of relapse than c-myc and c-erbB-2/neu amplifications in
primary human breast cancer. Mod Pathol. 7:900–905. 1994.PubMed/NCBI
|
|
18
|
Roy D, Calaf GM, Hande MP and Hei TK:
Allelic imbalance at 11q23–q24 chromosome associated with estrogen
and radiation-induced breast cancer progression. Int J Oncol.
28:667–674. 2006.
|
|
19
|
Calaf GM and Hei TK: Establishment of a
radiation- and estrogen-induced breast cancer model.
Carcinogenesis. 21:769–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soule H, Vazquez J, Long A, Albert S and
Brennan MA: A human cell line from a pleural effusion derived from
a breast carcinoma. J Natl Cancer Inst. 51:1409–1416.
1973.PubMed/NCBI
|
|
21
|
Roy D, Calaf GM and Hei TK: Profiling of
differentially expressed genes induced by high linear energy
transfer radiation in breast epithelial cells. Mol Carcinogen.
31:192–203. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roy D, Calaf G and Hei TK: Allelic
imbalance at 11p15.5–15.4 correlated with c-Ha-ras mutation during
radiation-induced neoplastic transformation of human breast
epithelial cells. Int J Cancer. 103:730–737. 2003.
|
|
23
|
Calaf GM, Roy D and Hei TK: Immunochemical
analysis of protein expression in breast epithelial cells
transformed by estrogens and high linear energy transfer (LET)
radiation. Histochem Cell Biol. 124:261–274. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Calaf G and Hei TK: Oncoprotein expression
in human breast epithelial cells transformed by high-LET radiation.
Int J Radiat Biol. 77:31–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gross-Bellard M, Oudet P and Chambon P:
Isolation of high-molecular-weight DNA from mammalian cells. Eur J
Biochem. 36:32–38. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sambrook J, Fritsch EF and Maniatis T:
Molecular Cloning A Laboratory Manual. 3. 2nd edition. Cold Spring
Harbor Laboratory Press; Plainview, NY: pp. 16261989
|
|
27
|
Jaeckel S, Epplen JT, Kauth M, Miterski B,
Tschentscher F and Epplen C: Polymerase chain reaction-single
strand conformation polymorphism or how to detect reliably and
efficiently each sequence variation in many samples and many genes.
Electrophoresis. 19:3055–3061. 1998. View Article : Google Scholar
|
|
28
|
Calaf GM and Roy D: Gene and protein
expressions induced by 17beta-estradiol and parathion in cultured
breast epithelial cells. Mol Med. 13:255–265. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Calaf GM and Roy D: Cell adhesion proteins
altered by 17β estradiol and parathion in breast epithelial cells.
Oncol Rep. 19:165–169. 2008.
|
|
30
|
Califano A: SPLASH: structural pattern
localization analysis by sequential histograms. Bioinformatics.
16:341–357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Calaf GM, Roy D, Narayan G and Balajee AS:
Differential expression of cell adhesion molecules in an ionizing
radiation-induced breast cancer model system. Oncol Rep.
30:285–291. 2013.PubMed/NCBI
|
|
32
|
Bieche I and Lidereau R: Genetic
alterations in breast cancer. Genes Chromosomes Cancer. 14:227–251.
1995. View Article : Google Scholar
|
|
33
|
Parsons R, Li GM, Longley MJ, Fang WH,
Papadopoulos N, Jen J, De la Chapelle A, Kinzler KW, Vogelstein B
and Modrich P: Hypermutability and mismatch repair deficiency in
RER+ tumor cells. Cell. 75:1227–1236. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dedhar S: Cell-substrate interactions and
signaling through ILK. Curr Opin Cell Biol. 12:250–256. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hilakivi-Clarke L: Estrogens, BRCA1, and
breast cancer. Cancer Res. 60:4993–5001. 2000.PubMed/NCBI
|
|
36
|
Liehr JG: Is estradiol a genotoxic
mutagenic carcinogen? Endocr Rev. 21:40–54. 2000.PubMed/NCBI
|
|
37
|
Berkey CS, Frazier AL, Gardner JD and
Colditz GA: Adolescence and breast carcinoma risk. Cancer.
85:2400–2409. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nagahata T, Hirano A, Utada Y, Tsuchiya S,
Takahashi K, Tada T, Makita M, Kasumi F, Akiyama F, Sakamoto G,
Nakamura Y and Emi M: Correlation of allelic losses and
clinicopathological factors in 504 primary breast cancers. Breast
Cancer. 9:208–215. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wilkerson PM and Reis-Filho JS: The
11q13-q14 amplicon: clinicopathological correlations and potential
drivers. Genes Chromosomes Cancer. 52:333–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Holm K, Staaf J, Jönsson G,
Vallon-Christersson J, Gunnarsson H, Arason A, Magnusson L,
Barkardottir RB, Hegardt C, Ringnér M and Borg A: Characterization
of amplification patterns and target genes at chromosome 11q13 in
CCND1-amplified sporadic and familial breast tumors. Breast Cancer
Res Treat. 133:583–594. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Saxon PJ, Srivatsan ES and Stanbridge EJ:
Introduction of human chromosome 11 via microcell transfer controls
tumorigenic expression of HeLa cells. EMBO J. 5:3461–3466.
1986.PubMed/NCBI
|
|
42
|
Shi ZZ, Jiang YY, Hao JJ, Zhang Y, Zhang
TT, Shang L, Liu SG, Shi F and Wang MR: Identification of putative
target genes for amplification within 11q13.2 and 3q27.1 in
esophageal squamous cell carcinoma. Clin Transl Oncol. 8:606–615.
2013.PubMed/NCBI
|
|
43
|
Jarmuz-Szymczak M, Pelinska K,
Kostrzewska-Poczekaj M, Bembnista E, Giefing M, Brauze D,
Szaumkessel M, Marszalek A, Janiszewska J, Kiwerska K, Bartochowska
A, Grenman R, Szyfter W and Szyfter K: Heterogeneity of 11q13
region rearrangements in laryngeal squamous cell carcinoma analyzed
by microarray platforms and fluorescence in situ hybridization. Mol
Biol Rep. 40:4161–4171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Su T, Han Y, Yu Y, Tan X, Li X, Hou J, Du
Y, Shen J, Wang G, Ma L, Jiang S, Zhang H and Cao G: A
GWAS-identified susceptibility locus on chromosome 11q13.3 and its
putative molecular target for prediction of postoperative prognosis
of human renal cell carcinoma. Oncol Lett. 6:421–426. 2013.
|
|
45
|
Chung CC, Boland J, Yeager M, Jacobs KB,
Zhang X, Deng Z, Matthews C, Berndt SI and Chanock SJ:
Comprehensive resequence analysis of a 123-kb region of chromosome
11q13 associated with prostate cancer. Prostate. 72:476–486. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Champème MH, Bièche I, Lizard S and
Lidereau R: 11q13 amplification in local recurrence of human
primary breast cancer. Genes Chromosomes Cancer. 12:128–133.
1995.PubMed/NCBI
|
|
47
|
Feinberg AP: Genomic imprinting and gene
activation in cancer. Nat Genet. 4:110–113. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Naidu R, Wahab NA, Yadav M, Kutty MK and
Nair S: Detection of amplified int-2/FGF-3 gene in primary breast
carcinomas using differential polymerase chain reaction. Int J Mol
Med. 8:193–198. 2001.PubMed/NCBI
|
|
49
|
Hajitou A, Deroanne C, Noël A, Collette J,
Nusgens B, Foidart JM and Calberg-Bacq CM: Progression in MCF-7
breast cancer cell tumorigenicity: compared effect of FGF-3 and
FGF-4. Breast Cancer Res Treat. 60:15–28. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dienstmann R, Rodon J, Prat A,
Perez-Garcia J, Adamo B, Felip E, Cortes J, Iafrate AJ, Nuciforo P
and Tabernero J: Genomic aberrations in the FGFR pathway:
opportunities for targeted therapies in solid tumors. Ann Oncol.
20:552–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
